Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the 'FlexTouch Pen'.
MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir ® FlexTouch ®, a disposable prefilled insulin pen containing Levemir ® (insulin detemir).
Biocorp, a French company specialized in the design, development, and manufacturing of innovative medical devices, announced an agreement with Novo Nordisk, a world leader in diabetes care, for the ...
LONDON, Oct 10, 2011 (BUSINESS WIRE) -- Novo Nordisk has today announced the launch of their new disposable prefilled insulin pen -- FlexTouch(R) - in the UK. FlexTouch(R) is available in the UK with ...
(RTTNews) - BIOCORP, a French medical devices company, announced Monday an agreement with Danish pharmaceutical company Novo Nordisk A/S (NVO) for the development and distribution of a Mallya smart ...
The US Food and Drug Administration (FDA) has approved Novo Nordisk's prefilled insulin pens NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] ...
People with diabetes have been hit with a five-month shortage of a vital medication. The Tresiba FlexTouch U100 insulin pen, which is manufactured by global pharmaceutical giant Novo Nordisk, is ...